409 related articles for article (PubMed ID: 7141787)
21. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[TBL] [Abstract][Full Text] [Related]
22. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
[TBL] [Abstract][Full Text] [Related]
23. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
[TBL] [Abstract][Full Text] [Related]
24. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
Schalm SW; Summerskill WH; Go VL
Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
26. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT; Yang LY
J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
[TBL] [Abstract][Full Text] [Related]
27. Plasma protein thiols and total antioxidant power in pediatric nephrotic syndrome.
Karthikeyan K; Sinha I; Prabhu K; Bhaskaranand N; Rao A
Nephron Clin Pract; 2008; 110(1):c10-4. PubMed ID: 18663332
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
Prandota J
Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
[TBL] [Abstract][Full Text] [Related]
29. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
Wagner JG; DiSanto AR; Gillespie WR; Albert KS
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
[TBL] [Abstract][Full Text] [Related]
30. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
[TBL] [Abstract][Full Text] [Related]
31. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
El Dareer SM; Struck RF; White VM; Mellett LB; Hill DL
Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
[TBL] [Abstract][Full Text] [Related]
32. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics of prednisone after oral administration in children with renal grafts. Changes induced by phenobarbital and renal insufficiency].
Perignon F; Pecquinot MA; Ged C; Antignac C; Guest G; Tete MJ; Broyer M; Lenoir G
Arch Fr Pediatr; 1985; 42 Suppl 1():639-44. PubMed ID: 3909980
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
Frey BM; Walker C; Frey FJ; de Weck AL
J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
Wasilewska A; Zoch-Zwierz W; Tenderenda E
Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
[TBL] [Abstract][Full Text] [Related]
37. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
Goszczyk A; Jung A; Bochniewska V; Straz-Zebrowska E
Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():25-6. PubMed ID: 11081338
[TBL] [Abstract][Full Text] [Related]
38. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
[TBL] [Abstract][Full Text] [Related]
39. [The influence of the initial prednisone treatment period on the adrenal function and the further course of the disease in steroid sensitive nephrotic syndrome in children].
Ksiazek J
Pediatr Pol; 1995 Jan; 70(1):15-23. PubMed ID: 7624163
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
Frey BM; Seeberger M; Frey FJ
Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
